Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001
August 06, 2014 at 06:06 AM EDT
Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that we have top-line results from two of the three bioequivalence (BE) ...